Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multinational, Multicentre, Open-label, Randomized Trial to Evaluate Safety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series Compared to Guideline-Directed Medical Therapy (GDMT) in Participants With Moderate Aortic Stenosis.

NCT07532317 is registered in ClinicalTrials.gov with Meril Life Sciences Pvt. Ltd. as lead sponsor.

NCT NCT07532317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07532317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multinational, Multicentre, Open-label, Randomized Trial to Evaluate Safety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series Compared to Guideline-Directed Medical Therapy (GDMT) in Participants With Moderate Aortic Stenosis.
Lead sponsor
Meril Life Sciences Pvt. Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 17, 2026
Completion date
May 12, 2041
Enrollment
778 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

moderate aortic stenosis